Genital Herpes
📧 Sign up to get email alerts when something new happens for Genital Herpes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes [Phase 1]
This Phase 1 study assessed the safety, pharmacokinetics, and antiviral activity of ABI-5366 in healthy participants and HSV-2 seropositive …
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes [Phase 1]
Phase 1 study to evaluate the safety, pharmacokinetics, and tolerability of ABI-1179 in healthy subjects and HSV-2 seropositive individuals …
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Viral Infections in Healthy and Immunocompromised Hosts
An NIAID-sponsored clinical trial is examining viral infections in healthy and immunocompromised hosts. It is currently recruiting and focus…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes [Phase 1, Phase 2]
A completed Phase 1/2 study by GlaxoSmithKline evaluated a targeted immunotherapy against herpes simplex virus, assessing safety, reactogeni…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes [Phase 1, Phase 2]
A Phase 1/2 clinical trial of mRNA-1608, Moderna's HSV-2 therapeutic vaccine, in healthy adults with recurrent genital herpes has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Study of 2LHERP® in Genital Herpes Infections [Phase 4]
Phase 4 trial update for 2LHERP® in genital herpes infections; study terminated.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes [Phase 2]
Phase 2 trial update for a new antiviral against Genital Herpes has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-03Clinical Trial Update: A Phase 2 Trial to Evaluate the Safety and Efficacy of UB-621 [Phase 2]
Phase 2 clinical trial update evaluating the safety and efficacy of UB-621 for genital herpes.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: UB-621, a New Type of Anti-herpes Simplex Virus (HSV) Monoclonal Antibody for the Use in the Treatment of Adult Recurrent HSV-2 Infections of the Genitals [Phase 2]
A Phase 2 clinical trial investigating UB-621, a monoclonal antibody targeting herpes simplex virus, for adult recurrent genital herpes infe…
-
CLINICAL_TRIALS trial_result · 2022-02-04Clinical Trial Update: Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2 [Phase 2]
Phase 2 trial update on a new antiviral for genital herpes type 2 (HSV-2) showing completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Melatonin Effects on Genital Herpes in Brazilian Women [Phase 4]
Phase 4 clinical trial evaluating melatonin effects on genital herpes in Brazilian women has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Comparative Effectiveness of Treatment Options for Genital Herpes Infection to Reduce Adverse Pregnancy Outcomes
Clinical trial assessing comparative effectiveness of treatment options for genital herpes infection to reduce adverse pregnancy outcomes; c…
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes [Phase 2]
Phase 2 trial evaluating the biological efficacy of HerpV vaccine with QS-21 for recurrent genital herpes due to HSV-2; study completed and …
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons [Phase 4]
A Phase 4 clinical trial studying suppression and treatment of genital herpes infection in HIV-infected individuals was terminated.
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: The VIBLOK SAfety and perFormancE Trial [NA]
Clinical trial update for a safety and performance study related to HSV-2 infection/genital herpes; status completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: Effect of HSV-2 Suppressive Therapy on Sexual Behavior [Phase 4]
Phase 4 trial investigating the effect of HSV-2 suppressive therapy on sexual behavior in individuals with genital herpes; study terminated …
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating DNA vaccines for genital herpes caused by HSV-2; trial completed.
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection [Phase 2]
Phase 2 maintenance-dose study of GEN-003 in subjects with genital herpes (HSV-2 infection) was terminated; results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies. [Phase 4]
Phase 4 trial comparing daily valacyclovir to placebo for suppression of genital herpes (HSV-2) in newly diagnosed patients; study completed…
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission [Phase 3]
Phase 3 clinical trial update on HSV-2 suppression to reduce HIV transmission in individuals with HIV infection and genital herpes; study co…
-
CLINICAL_TRIALS trial_result · 2018-06-01Clinical Trial Update: Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine [Phase 1, Phase 2]
Completion of a Phase 1/Phase 2 safety and immunogenicity study of a therapeutic vaccine for genital herpes caused by HSV-2, conducted by Ge…
-
CLINICAL_TRIALS trial_result · 2018-03-23Clinical Trial Update: VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2 [Phase 4]
A Phase 4 trial assessed once-daily valacyclovir (Valtrex) for reducing HSV-2 viral shedding in individuals newly diagnosed with genital her…
-
CLINICAL_TRIALS trial_result · 2018-02-12Clinical Trial Update: VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies. [Phase 4]
Phase 4 trial updating viral shedding results for VALTREX (valacyclovir) in HSV-2 seropositive subjects; study completed with results posted…
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes [Phase 2]
A Phase 2 study of ASP2151 in subjects with recurrent genital herpes has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-16Clinical Trial Update: Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine [Phase 2]
Phase 2 dose-ranging study of a therapeutic HSV-2 vaccine by Genocea Biosciences completed, reporting safety and efficacy data in genital he…